Q5123 — Injection, rituximab-arrx, biosimilar, (riabni), 10 mg

What the market charges

Across 2,012 negotiated rates, the middle 80% fall between $18 and $71, with a median of $34.

What Medicare pays

Medicare allowed an average of $40 for this code, across 512,172 services billed by 189 providers. At the median, the market charges less than Medicare pays for this code — 15% less.

Where this is billed, and what it costs there

The states billing Q5123 most, by Medicare service volume, each compared against the national average of $40. Each links to the providers Mishe lists there.

  • Florida — 49 providers billed it, Medicare allowed $40 — level with the national average
  • Arkansas — 26 providers billed it, Medicare allowed $40 — level with the national average
  • California — 24 providers billed it, Medicare allowed $39 — 2% below the national average
  • Illinois — 11 providers billed it, Medicare allowed $40 — level with the national average
  • Tennessee — 13 providers billed it, Medicare allowed $40 — level with the national average
  • Michigan — 8 providers billed it, Medicare allowed $40 — level with the national average
  • South Carolina — 7 providers billed it, Medicare allowed $40 — level with the national average
  • Georgia — 7 providers billed it, Medicare allowed $39 — 2% below the national average

Deploy this for your team

Every figure on this page came from published payer and Medicare data, assembled by Mishe. The same pricing, claim-editing and care-pathway intelligence runs underneath the plans Mishe operates.

Take back healthcare.